SSTR2 and nasopharyngeal carcinoma: in a study of primary, recurrent, and/or undifferentiated nasopharyngeal carcinomas, showed multifocal to diffuse strong SSTR2 expression in 90% of tumors including 8 of 9 EBV-associated and one EBV-negative nasopharyngeal carcinoma (37).